Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Posts tagged Cadila Healthcare

Daljeet Kohli Stock Pick Cadila Healthcare Surges



Daljeet Kohli of IndiaNivesh has mastered the art of homing in on stocks just before they perk up. Apart from Alembic and J. B. Chemical, Cadila is another example of this splendid stock selection

Check Out Daljeet Kohli’s Latest Pharma Stock Pick: Cadila Healthcare



Daljeet Kohli of IndiaNivesh is obviously buoyed by the success of his earlier two stock picks, Alembic Pharma & J. B. Chem. Both stocks have given hefty returns and are still looking good for more gains. His latest stock pick, Cadila Healthcare, has been an under-performer so far. However, a re-rating is on the cards for Cadila and there will be a 20% gain, says Daljeet confidently

Newer Entries →

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 495 other subscribers

RSS Stocks Talk Forum

  • Sunil Singhania & Madhu Kela are bullish about Himatsingka Seide
    Sunil Singhania & Madhu Kela are bullish about Himatsingka Seide. Singhania's Abakkus Fund holds 6.78% worth ₹137 Cr. Kela's Cohesion MK Fund holds 4.07% worth ₹82 Cr. M-Cap is ₹2100 Cr. Promoters hold 37%. Co is dominant in branded Home Textile with a 'fibre to shelf' model
  • Suraj Estate Developers has a robust project lineup & launch pipeline. TP ₹992 (+73%)
    Suraj Estate Developers has a robust project lineup & launch pipeline, leadership position in redevelopment projects, strong cost advantage, proven track record, huge addressable market and healthy Balance Sheet with predictable cash flows. TP ₹992 (+73%) Download research report... Suraj Estate Developers has a robust project lineup & launch pipeline. TP ₹992 (+73%)
  • DCX Systems has the ability to become a key player in EMS space. TP ₹466 (+54%)
    DCX Systems has the ability to become a key player in EMS space with huge potential in railway & defence. It has ability to deliver high value complicated & critical products for leading defense players L&T & Lockheed. Order book ₹3000 Cr. TP ₹466 (+54%) Download... DCX Systems has the ability to become a key […]
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!